{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:44:08Z","timestamp":1767923048197,"version":"3.49.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/mph.0b013e31827e8662","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T15:16:45Z","timestamp":1360163805000},"page":"e153-e156","source":"Crossref","is-referenced-by-count":14,"title":["G\u03b3- Xmn I Polymorphism"],"prefix":"10.1097","volume":"35","author":[{"given":"Saqib H.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir S.","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saima","family":"Munzir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed T.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajida","family":"Erum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousar","family":"Perveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasneem","family":"Farzana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushtaq","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabassum","family":"Mehboob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moinuddin","family":"Moinuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-26-20210227","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11033-009-9566-7","article-title":"The Xmn1 polymorphic site 5 to the G gene and its correlation to the G:A ratio, age at first blood transfusion and clinical features in -thalassemia patients from Western Iran.","volume":"37","author":"Nemati","year":"2010","journal-title":"Mol Biol Rep"},{"key":"R2-26-20210227","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood.V66.4.783.783","article-title":"DNA sequence variation associated with elevated fetal Gg globin production.","volume":"66","author":"Gilman","year":"1985","journal-title":"Blood"},{"key":"R3-26-20210227","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bcmd.2010.11.002","article-title":"Xmn I polymorphism associated with concomitant activation of G and A globin gene transcription on a 0-thalassemia chromosome.","volume":"46","author":"Haj Khelil","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"R4-26-20210227","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2010.01422.x","article-title":"Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major.","volume":"84","author":"Sharma","year":"2010","journal-title":"Eur J Hematol"},{"key":"R5-26-20210227","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajh.21120","article-title":"Response to hydroxyurea therapy in -thalassemia.","volume":"83","author":"Koren","year":"2008","journal-title":"Am J Hematol"},{"key":"R6-26-20210227","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","article-title":"Hydroxyurea can eliminate transfusion requirements in children with severe -thalassemia.","volume":"102","author":"Bradai","year":"2003","journal-title":"Blood"},{"key":"R7-26-20210227","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/03630260701285050","article-title":"Genotypic correlation between six common -thalassaemia mutations and the XmnI polymorphism in the Moroccan population.","volume":"31","author":"Agouti","year":"2007","journal-title":"Hemoglobin"},{"key":"R8-26-20210227","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00043426-200011000-00026","article-title":"Genetic factors affecting clinical severity in -thalassaemia syndromes.","volume":"22","author":"Winichagoon","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"R9-26-20210227","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00277-003-0836-5","article-title":"Hydroxyurea in the treatment of major b-thalassaemia and importance of genetic screening.","volume":"83","author":"Alebouyeh","year":"2004","journal-title":"Ann Hematol"},{"key":"R10-26-20210227","first-page":"380","article-title":"Hydroxyurea use in Lebanese patients with b-thalassaemia intermedia.","volume":"27","author":"Taher","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R11-26-20210227","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.mph.0000174386.13109.28","article-title":"Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran.","volume":"27","author":"Karimi","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"R13-26-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00277-005-1026-4","article-title":"Hydroxyurea in thalassaemia intermediaa promising therapy.","volume":"84","author":"Dixit","year":"2005","journal-title":"Ann Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e31827e8662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:14:19Z","timestamp":1620965659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201305000-00026"}},"subtitle":["A Significant Determinant of \u03b2-Thalassemia Treatment Without Blood Transfusion"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31827e8662","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}